Comparing Canadian TIA Score and ABCD2 Score for Stroke Risk in TIA Patients
Canadian TIA Score Versus ABCD2 Score in Risk Stratification of Transient Ischemic Attack (TIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06718075
This study is testing whether the Canadian TIA score is better than the ABCD2 score at predicting stroke risk in patients who have had a transient ischemic attack (TIA).
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06718075 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of the Canadian TIA score compared to the ABCD2 score in predicting the risk of stroke or carotid revascularization in patients who have experienced a transient ischemic attack (TIA). Conducted at the Emergency Medicine department of IRCCS AOU di Bologna, the study will enroll approximately 800 adult patients over a 24-month period. Prognostic scores will be assessed at the time of admission, and follow-up will occur at 7 and 90 days post-admission to monitor outcomes. The goal is to identify high-risk patients for optimized management and treatment.
Who should consider this trial
Good fit: Ideal candidates include all adult patients presenting to the emergency department with a diagnosis of transient ischemic attack.
Not a fit: Patients who do not present with a transient ischemic attack or those who cannot provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk stratification and management of patients following a transient ischemic attack, potentially reducing the incidence of subsequent strokes.
How similar studies have performed: While the ABCD2 score has been widely used, the Canadian TIA score is a newer approach that has not been extensively validated outside of Canada, making this study a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients presenting to the emergency department with a diagnosis of TIA * all adult patients * all patients who have signed the informed consent Exclusion Criteria: * none
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Veronica Salvatore, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Veronica Salvatore, MD
- Email: veronica.salvatore@aosp.bo.it
- Phone: +39 0512144716
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Transient Ischemic Attack